Download PDFPDF
Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Association between quantitative anti-CCP levels and HLA-DR4 expression in rheumatoid arthritis
    • Zoltán Szekanecz, Professor of Rheumatology, Medicine and Immunology
    • Other Contributors:
      • Anikó Kapitány, Zoltán Szabó, Lilla Soós, Sándor Sipka, Gabriella Lakos

    Sir, In their study, Lee et al (1) studied possible associations between anti-CCP titers and several markers of disease pathogenesis and activity of rheumatoid arthritis (RA)including the presence of erosions, CRP, ESR, disease duration and history of smoking. They report a significant association between anti-CCP titers and history of smoking. Authors are right that the vast majority of anti-CCP studies only deal with the p...

    Show More
    Conflict of Interest:
    None declared.